American Century Companies’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
WP
NCM
American Century Companies's ZVRA Position: Q2 2026 in Review
American Century Companies opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 52,903 shares worth $759K. The stake represents ﹤0.01% of the portfolio and ranks #2487 among its holdings. This is a return to the name: American Century Companies previously reported a position in ZVRA as recently as Q1 2024.
American Century Companies first reported a position in ZVRA in Q2 2023 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.
- American Century Companies held 52,903 shares of Zevra Therapeutics worth $759K as of Q2 2026.
- Zevra Therapeutics was a new American Century Companies position in Q2 2026.
- Zevra Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2487 holding.
- American Century Companies first reported a position in Zevra Therapeutics in Q2 2023 and has held it in 5 quarters since.
- 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.